AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RIFAMYCINE
8 registrations across 4 African markets— 5 active
Markets with RIFAMYCINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| RIFAMYCINE CHIBRET Collyre / 1MUI pour cent | 🇹🇳Tunisia | THEA | expired | May 2004 |
| RIFOCINE Solution injectable / 250 MG | 🇹🇳Tunisia | SANOFI-AVENTIS S.p.A | expired | Nov 1994 |
| OTOFA Gouttes auriculaires | 🇹🇳Tunisia | BOUCHARA-RECORDATI | expired | Apr 1990 |
| RIFAMYCINE® CHIBRET 1 000 000 UI% COLY SOL BTE (1 FL X 10ML) collyre en solution, boîte de 1 | 🇲🇬Madagascar | LABORATOIRES THEA S.A.S | active | — |
| OTOFA solution / 200 mg | 🇸🇳Senegal | BOUCHARA | active | — |
| RIFOREIL SOLUTION POUR GOUTTE AURICULAIRE | 🇲🇦Morocco | — | active | — |
| OTOFA SOLUTION POUR GOUTTE AURICULAIRE | 🇲🇦Morocco | — | active | — |
| RIFAMYCINE® CHIBRET 1 000 000 UI% COLY SOL BTE (1 FL X 10ML) collyre en solution, boîte de 1 | 🇲🇬Madagascar | LABORATOIRES THEA S.A.S | active | — |
RIFAMYCINE in Africa — Regulatory Overview
RIFAMYCINE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Madagascar, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 5 (63%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.